NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
school
University Rankings
subject
University Subject Rankings
insights
Subject Rankings
place
Country Rankings
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Mohini Ranganathan
Yale University - New Haven / United States
Medical and Health Sciences / Psychiatry
AD Scientific Index ID: 829255
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Mohini Ranganathan's MOST POPULAR ARTICLES
1-)
The acute effects of cannabinoids on memory in humans: a reviewM Ranganathan, DC D’SouzaPsychopharmacology 188 (4), 425-444, 20066052006
2-)
Cannabis and psychosis/schizophrenia: human studiesDC D’Souza, RA Sewell, M RanganathanEuropean archives of psychiatry and clinical neuroscience 259 (7), 413-431, 20093682009
3-)
Blunted psychotomimetic and amnestic effects of Δ-9-tetrahydrocannabinol in frequent users of cannabisDC D\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'souza, M Ranganathan, G Braley, R Gueorguieva, Z Zimolo, ...Neuropsychopharmacology 33 (10), 2505-2516, 20083082008
4-)
Clinical and preclinical evidence for functional interactions of cannabidiol and Δ9-tetrahydrocannabinolDL Boggs, JD Nguyen, D Morgenson, MA Taffe, M RanganathanNeuropsychopharmacology 43 (1), 142-154, 20182592018
5-)
The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trialDL Boggs, T Surti, A Gupta, S Gupta, M Niciu, B Pittman, ...Psychopharmacology 235, 1923-1932, 20182492018
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept